Clarke Barlow, Director at Tryptamine Therapeutics, holds 508.00K shares in Tryptamine Therapeutics (Ticker: AU:TYP). Most recently, Clarke Barlow ― shares of Tryptamine Therapeutics on ― for an estimated value of ―.
What is the percentage of profitable transactions made by Clarke Barlow?
The percentage of profitable transactions made by Clarke Barlow is ―.
What is the average return per transaction made by Clarke Barlow?
The average return per transaction made by Clarke Barlow is ―.
What stocks does Clarke Barlow hold?
Clarke Barlow holds: AU:TYP stocks.
What was Clarke Barlow’s latest transaction?
Clarke Barlow latest transaction was an Uninformative Buy of ―.
What was Clarke Barlow's most profitable transaction?
Clarke Barlow’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Clarke Barlow's role in Tryptamine Therapeutics?
Clarke Barlow's role in Tryptamine Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.